semaglutide treatments Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes Semaglutide and Tirzepatide for Weight

Always check your medication label for the specific product guidelines

Reporting and Monitoring Adverse Effects: Yellow Card Scheme and MHRA Guidance The Yellow Card Scheme , operated by the MHRA and the Commission on Human Medicines (CHM), is the UK's system for collecting information on suspected adverse drug reactions

We understand that some of our patients may be doing this, and if they are, wed like to know about it and still be on their health journey with them, says Kumar

When muscle mass drops too much: Your metabolism slows down , so you burn fewer calories You lose strength, stability, and energy You may regain fat more easily after stopping the medication You increase your risk of long-term frailty and poor body composition The goal isnt just to lose weight its to lose fat while keeping (or gaining) strength